We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
Cap. Flow
-$438M
Cap. Flow %
-78.37%
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331

Top Buys

Rank Stock Value
1
ALLK
Allakos
ALLK
+$25.1M
2
MRK icon
Merck
MRK
+$9.57M
3
INFO
IHS Markit Ltd. Common Shares
INFO
+$9.37M
4
BBIO icon
BridgeBio Pharma
BBIO
+$9.02M
5
MRVL icon
Marvell Technology
MRVL
+$7.11M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$10.5M
2
C icon
Citigroup
C
+$10.5M
3
MSFT icon
Microsoft
MSFT
+$9.87M
4
OPTU
Optimum Communications Inc
OPTU
+$9.41M
5
AES icon
AES
AES
+$7.92M

Sector Composition

Rank Sector Weight
1 Technology 25.93%
2 Consumer Discretionary 17.95%
3 Healthcare 12.14%
4 Communication Services 8.7%
5 Financials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARES icon
451
Ares Management
ARES
$30.9B
– –
-9,900
Closed -$731K
ASAN icon
452
Asana
ASAN
$1.96B
– –
-18,732
Closed -$1.95M
ASB icon
453
Associated Banc-Corp
ASB
$5.92B
– –
-28,109
Closed -$602K
ASO icon
454
Academy Sports + Outdoors
ASO
$2.97B
– –
-48,118
Closed -$1.93M
ATKR icon
455
Atkore
ATKR
$3.16B
– –
-2,465
Closed -$214K
ATR icon
456
AptarGroup
ATR
$8.66B
– –
-1,800
Closed -$215K
OPTU
457
Optimum Communications Inc
OPTU
$315M
– –
-454,024
Closed -$9.41M
AUPH icon
458
Aurinia Pharmaceuticals
AUPH
$2.06B
– –
-288,840
Closed -$6.39M
AVIR icon
459
Atea Pharmaceuticals
AVIR
$387M
– –
-44,320
Closed -$1.55M
AVY icon
460
Avery Dennison
AVY
$13.1B
– –
-5,400
Closed -$1.12M
AZEK
461
DELISTED
The AZEK Co
AZEK
– –
-18,749
Closed -$685K
BA icon
462
Boeing
BA
$184B
– –
-32,521
Closed -$7.15M
BAH icon
463
Booz Allen Hamilton
BAH
$8.91B
– –
-14,604
Closed -$1.16M
BAX icon
464
Baxter International
BAX
$14.2B
– –
-79,804
Closed -$6.42M
BCRX icon
465
BioCryst Pharmaceuticals
BCRX
$2.39B
– –
-50,132
Closed -$720K
BEN icon
466
Franklin Resources
BEN
$17.4B
– –
-51,996
Closed -$1.54M
BFAM icon
467
Bright Horizons
BFAM
$3.86B
– –
-2,900
Closed -$404K
BJ icon
468
BJs Wholesale Club
BJ
$12.3B
– –
-10,799
Closed -$593K
BKE icon
469
Buckle
BKE
$2.39B
– –
-23,300
Closed -$922K
BKR icon
470
Baker Hughes
BKR
$62.3B
– –
-66,136
Closed -$1.64M
BL icon
471
BlackLine
BL
$1.75B
– –
-3,675
Closed -$434K
BLDP
472
Ballard Power Systems
BLDP
$778M
– –
-38,815
Closed -$545K
BLMN icon
473
Bloomin' Brands
BLMN
$917M
– –
-15,677
Closed -$392K
BMY icon
474
Bristol-Myers Squibb
BMY
$130B
– –
-177,285
Closed -$10.5M
BOOT icon
475
Boot Barn
BOOT
$5.06B
– –
-14,936
Closed -$1.33M
17 18
19
20 21

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.

  • Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
  • Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
  • Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
  • Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
  • Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
  • Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
  • Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.

Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.